AMA calls for ban on direct-to-consumer ads

The American Medical Association is calling for a ban on direct-to-consumer ads for prescription drugs and medical devices. The organization is citing their contribution to rising costs and patient demands for improper treatment as the reason. It’s something Ocean City physician Dr. Victor Gong says he fully supports.

Dr. Gong goes on, “It’s certainly a new age of patients. They have more information at their fingertips which is great. However, they come in with their Web MD sheet, their advertising sheet from the pharmaceuticals, and it can be a challenge.”

According to the AMA, ad dollars spent by drug companies have risen thirty percent in the last two years, to $4.5 billion. Prices for prescription drugs have risen nearly five percent this year. Dr. Gong says these costs can end up compromising patient care.    

He replies, “A lot of times you’re pressured into giving them the medications. Then, they find out the insurance won’t cover it, the price is too high, and they call you back. They’ve got to switch the medications back to something else.”

Going through that process can delaying treatment. However, the pharmaceutical industry is opposing the AMA’s position. 

In an interview with the Associated Press, Tina Stow with Pharmaceutical Research and Manufacturers of America said that direct-to-consumer ads aim to give, “scientifically accurate information to patients so that they are better informed about their health care and treatment options,” However, physicians like Dr. Gong believe that can all be handled in the office.

He continues, “I rather educate the patient on their disease process; rather than just on a specific medication that may not be suited for them.”  

47 ABC spoke with a representative from the AMA on Thursday that says their strategy for implementing the ban is currently under development.